These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 3952123)

  • 1. Studies of the relationship between molecular structure and hallucinogenic activity.
    Nichols DE
    Pharmacol Biochem Behav; 1986 Feb; 24(2):335-40. PubMed ID: 3952123
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hallucinogens as discriminative stimuli in animals: LSD, phenethylamines, and tryptamines.
    Winter JC
    Psychopharmacology (Berl); 2009 Apr; 203(2):251-63. PubMed ID: 18979087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Receptor interaction profiles of novel psychoactive tryptamines compared with classic hallucinogens.
    Rickli A; Moning OD; Hoener MC; Liechti ME
    Eur Neuropsychopharmacol; 2016 Aug; 26(8):1327-37. PubMed ID: 27216487
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemistry and Structure-Activity Relationships of Psychedelics.
    Nichols DE
    Curr Top Behav Neurosci; 2018; 36():1-43. PubMed ID: 28401524
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of ring fluorination on the pharmacology of hallucinogenic tryptamines.
    Blair JB; Kurrasch-Orbaugh D; Marona-Lewicka D; Cumbay MG; Watts VJ; Barker EL; Nichols DE
    J Med Chem; 2000 Nov; 43(24):4701-10. PubMed ID: 11101361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dihydrobenzofuran analogues of hallucinogens. 4. Mescaline derivatives.
    Monte AP; Waldman SR; Marona-Lewicka D; Wainscott DB; Nelson DL; Sanders-Bush E; Nichols DE
    J Med Chem; 1997 Sep; 40(19):2997-3008. PubMed ID: 9301661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Substituted naphthofurans as hallucinogenic phenethylamine-ergoline hybrid molecules with unexpected muscarinic antagonist activity.
    Monte AP; Marona-Lewicka D; Lewis MM; Mailman RB; Wainscott DB; Nelson DL; Nichols DE
    J Med Chem; 1998 Jun; 41(12):2134-45. PubMed ID: 9622555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular connectivity analysis of hallucinogenic mescaline analogs.
    Glennon RA; Kier LB; Shulgin AT
    J Pharm Sci; 1979 Jul; 68(7):906-7. PubMed ID: 458614
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Indolealkylamine and phenalkylamine hallucinogens: a brief overview.
    Glennon RA; Rosecrans JA
    Neurosci Biobehav Rev; 1982; 6(4):489-97. PubMed ID: 6757811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A relationship between the hallucinogenic activity of drugs and their electronic configuration.
    Snyder SH; Merril CR
    Proc Natl Acad Sci U S A; 1965 Jul; 54(1):258-66. PubMed ID: 5216361
    [No Abstract]   [Full Text] [Related]  

  • 11. Quantitative structure-activity studies on hallucinogenic mescaline analogs using modified first order valence connectivity.
    Gupta SP; Bindal MC; Singh P
    Arzneimittelforschung; 1982; 32(10):1223-5. PubMed ID: 6891219
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 1-Aminomethylbenzocycloalkanes: conformationally restricted hallucinogenic phenethylamine analogues as functionally selective 5-HT2A receptor agonists.
    McLean TH; Parrish JC; Braden MR; Marona-Lewicka D; Gallardo-Godoy A; Nichols DE
    J Med Chem; 2006 Sep; 49(19):5794-803. PubMed ID: 16970404
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new view of the structural relationship between LSD and mescaline.
    Nichols DE; Pfister WR; Yim GK; Cosgrove RJ
    Brain Res Bull; 1977; 2(3):169-71. PubMed ID: 890502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Indolealkylamine and phenalkylamine hallucinogens. Effect of alpha-methyl and N-methyl substituents on behavioral activity.
    Glennon RA; Young R; Jacyno JM
    Biochem Pharmacol; 1983 Apr; 32(7):1267-73. PubMed ID: 6573879
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Severe aggression in rats induced by mescaline but not other hallucinogens.
    Sbordone RJ; Wingard JA; Gorelick DA; Elliott ML
    Psychopharmacology (Berl); 1979; 66(3):275-80. PubMed ID: 119274
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Psychotomimetic drugs: biochemistry and pharmacology.
    Brimblecombe RW
    Adv Drug Res; 1973; 7():165-206. PubMed ID: 4613150
    [No Abstract]   [Full Text] [Related]  

  • 17. LSD and phenethylamine hallucinogens: new structural analogy and implications for receptor geometry.
    Nichols DE; Pfister WR; Yim GK
    Life Sci; 1978 Jun; 22(24):2165-70. PubMed ID: 672453
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparison of the behavioral effects of mescaline analogs using the head twitch response in mice.
    Halberstadt AL; Chatha M; Chapman SJ; Brandt SD
    J Psychopharmacol; 2019 Mar; 33(3):406-414. PubMed ID: 30789291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Steric and electronic relationships among some hallucinogenic compounds.
    Kang S; Green JP
    Proc Natl Acad Sci U S A; 1970 Sep; 67(1):62-7. PubMed ID: 5272329
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure-activity-relationships of certain hallucinogenic substances based on brain levels.
    Vogel WH; Evans BD
    Life Sci; 1977 May; 20(10):1629-35. PubMed ID: 69244
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.